Fernanda Hernández-Alomia

Ms. Fernanda Hernández-Alomia

Investigación y Vinculación, Universidad de Las Américas, Quito, Pichincha, Ecuador
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
FHFernanda Hernández-Alomia
Fernanda Hernández-Alomia
CBCarlos Andres Bastidas-Caldes
Carlos Andres Bastidas-Caldes
IBIsabel Ballesteros
Isabel Ballesteros
Gabriela N. TeneaGabriela N. Tenea
Gabriela N. Tenea
PJPablo Jarrín-V.
Pablo Jarrín-V.
PCPablo Castillejo
Pablo Castillejo
Multidrug-resistant bacteria present resistance mechanisms against β-lactam antibiotics, such as Extended-Spectrum Beta-lactamases (ESBL) and Metallo-β-lactamases enzymes (MBLs) which are operon encoded in Gram-negative species. Likewise, Gram-positive bacteria have evolved other mechanisms through mec genes, which encode modified penicillin-binding proteins (PBP2). This study aimed to determine the presence and spread of β-lactam antibiotic resistance genes and the microbiome circulating in Quito’s Public Transport (QTP). A total of 29 station turnstiles were swabbed to extract the surface environmental DNA. PCRs were performed to detect the presence of 13 antibiotic resistance genes and to identify and to amplify 16S rDNA for barcoding, followed by clone analysis, Sanger sequencing, and BLAST search. ESBL genes blaTEM-1 and blaCTX-M-1 and MBL genes blaOXA-181 and mecA were detected along QPT stations, blaTEM being the most widely spread. Two subvariants were found for blaTEM-1, blaCTX-M-1, and blaOXA-181. Almost half of the circulating bacteria found at QPT stations were common human microbiota species, including those classified by the WHO as pathogens of critical and high-priority surveillance. β-lactam antibiotic resistance genes are prevalent throughout QPT. This is the first report of blaOXA-181 in environmental samples in Ecuador. Moreover, we detected a new putative variant of this gene. Some commensal coagulase-negative bacteria may have a role as mecA resistance reservoirs.

27 January 2025 in Foods
Verified
Journal Article
Open access
PDF file
ALAnthony Loor
Anthony Loor
MCMarcela Alejandra Robayo Chico
Marcela Alejandra Robayo Chico
BTByron Puga Torres
Byron Puga Torres
FHFernanda Hernández-Alomia
Fernanda Hernández-Alomia
SSSilvana Santander-Parra
Silvana Santander-Parra
LNLuis Nuñez
Luis Nuñez
Escherichia coli (E. coli), especially the Shiga toxin-producing O157:H7 strain, poses severe health risks. In rural Ecuador, raw milk consumption heightens contamination risks. This study analyzed 633 raw milk samples from Pichincha and Manabí to assess E. coli O157:H7 prevalence. The samples were enriched using BHI broth, and then specific culture media were used to isolate E. coli O157:H7. The pathogen in the enriched raw milk was identified, and the isolates were specifically confirmed through the application of a newly designed qPCR assay. The novel qPCR assay demonstrated remarkable sensitivity, capable of detecting up to one copy of genetic material, and specificity (no amplification of other bacteria). An extremely high E. coli O157:H7 prevalence of 0.63 (n = 401) was detected, where the province with the highest number of positive samples was Manabí with 72.8% (n = 225/309) and 54.3% (n = 179/324) for Pichincha. In both provinces, the presence of E. coli O157:H7 contamination exhibited a favorable correlation with small-scale farms and elevated temperatures. This research provides valuable data on the microbiological contamination of E. coli O157:H7 present in raw milk, in addition to an improved method that has been demonstrated to be faster, more sensitive, and more specific than conventional and previously published methods, highlighting the associated risk of food-borne infections and pointing out potential shortcomings in the regulation of agricultural practices and the need for periodic monitoring of bacterial contamination levels with updated methods.

12 December 2025 in Fermentation
Verified
Journal Article
Open access
PDF file
JRJessica De la Caridad Rodriguez
Jessica De la Caridad Rodriguez
DVDomenica Lizeth Villavicencio
Domenica Lizeth Villavicencio
ARAlys Raza
Alys Raza
FHFernanda Hernández-Alomia
Fernanda Hernández-Alomia
CBCarlos Andres Bastidas-Caldes
Carlos Andres Bastidas-Caldes
MCMaría Alejandra Cruz
María Alejandra Cruz
The production of craft beer depends on the quality and availability of yeast. However, many small breweries in developing countries face high costs due to their reliance on imported yeast strains. Developing efficient and low-cost propagation methods is therefore essential for sustainable production. A lager-type Saccharomyces cerevisiae strain (SC-Lager2) was propagated using both synthetic and low-cost alternative media. The latter was formulated with malt extract as a carbon source and yeast extract obtained from brewery by-products as a nitrogen source. A Plackett–Burman design identified significant factors influencing growth (p < 0.05), and a full factorial design (24) optimized conditions. Growth kinetics and biomass yield were validated at laboratory (2 L) and pilot (83 L) scales. Maltose, yeast extract, zinc sulfate, and agitation significantly affected cell density and viability (p < 0.05). Under optimized conditions, 100% viability, a maximum cell density of 1.4 × 1010 cells/mL, and a biomass yield of 10 g/L were achieved values that were statistically higher (p < 0.05) than those obtained with the synthetic medium. The maximum specific growth rate (μmax) increased by 52%, while doubling time decreased by 39%. Overall, the use of agro-industrial by-products reduced medium costs by approximately 65% compared to conventional synthetic formulations. The proposed low-cost medium provides a scalable, economical, and sustainable solution for yeast propagation, reducing production costs while maintaining high cell viability and performance. This approach supports the autonomy and competitiveness of the craft beer sector in developing regions.

21 February 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
CPClara Pazos
Clara Pazos
Miguel GualotoMiguel Gualoto
Miguel Gualoto
Tania Elizabeth Oña-RochaTania Elizabeth Oña-Rocha
Tania Elizabeth Oña-Rocha
Elizabeth Velarde-CruzElizabeth Velarde-Cruz
Elizabeth Velarde-Cruz
Karen PortillaKaren Portilla
Karen Portilla
CBCarlos Andres Bastidas-Caldes
Carlos Andres Bastidas-Caldes
The phenomenon of antimicrobial resistance (AMR) in cold environments, exemplified by the Antarctic, calls into question the assumption that pristine ecosystems lack clinically significant resistance genes. This study examines the molecular basis of AMR in Acinetobacter spp. Isolated from Antarctic soil, focusing on the blaTEM and blaSHV genes associated with extended-spectrum beta-lactamase (ESBL) production; Soil samples were collected and processed to isolate Antarctic soil bacteria. Molecular detection was then conducted using polymerase chain reaction (PCR) to identify the bacteria species by 16S rRNA/rpoB and 10 different beta-lactamase-producing genes. PCR amplicons were sequenced to confirm gene identity and analyze genetic variability. Acinetobacter baumannii were identified by both microbiological and molecular tests. Notably, both the blaTEM and blaSHV genes encoding the enzymes responsible for resistance to penicillins and cephalosporins were identified, indicating the presence of resistance determinants in bacteria from extreme cold ecosystems. The nucleotide sequence analysis indicated the presence of conserved ARGs, which suggest stability and the potential for horizontal gene transfer within microbial communities. These findings emphasize that AMR is not confined to human-impacted environments but can emerge and persist in remote, cold habitats, potentially facilitated by natural reservoirs and global microbial dispersal. Understanding the presence and role of AMR in extreme environments provides insights into its global dissemination and supports the development of strategies to mitigate the spread of resistance genes in both environmental and clinical contexts.

31 December 2025 in International Journal for Parasitology: Parasites and Wildlife
Verified
Journal Article
Open access
MCManuel Calvopiña
Manuel Calvopiña
CBCarlos Andres Bastidas-Caldes
Carlos Andres Bastidas-Caldes
FHFernanda Hernández-Alomia
Fernanda Hernández-Alomia
WCWilliam Cevallos
William Cevallos
Richar Ivan Rodríguez-HidalgoRichar Ivan Rodríguez-Hidalgo
Richar Ivan Rodríguez-Hidalgo
HSHiromu Sugiyama
Hiromu Sugiyama
This study reports the genetic characterization of Anisakidae larvae infecting the flathead grey mullet (Mugil cephalus) fish. Larvae were recovered from fish captured by artisanal fisheries and sold in a coastal town in northwestern Ecuador. In total, 19 larvae were obtained from nine fish, all larvae were exclusively encysted within the muscle tissue. Molecular identification was performed by PCR amplification and DNA sequencing of the nuclear ribosomal region ITS1-5.8 S-ITS2, the mitochondrial cox2 gene, and the EF-1α gene. Comparative analyses with sequences available in GenBank, followed by phylogenetic reconstruction, confirmed the larvae as Contracaecum overstreeti. This constitutes the first molecular evidence of C. overstreeti in this edible fish from Ecuador and provides new host–parasite records. The identification of this zoonotic nematode in marine fish of human consumption underscores the need for expanded surveillance in other neotropical marine ecosystems and in other commercially important fish species and highlights potential infection to humans.

10 August 2026 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
CBCarlos Andres Bastidas-Caldes
Carlos Andres Bastidas-Caldes
FHFernanda Hernández-Alomia
Fernanda Hernández-Alomia
FBFrancisco Bolaños
Francisco Bolaños
EVEmily Sofhía Cisneros Vásquez
Emily Sofhía Cisneros Vásquez
DRDaniel Romero-Alvarez
Daniel Romero-Alvarez
Antimicrobial resistance (AMR) represents one of the most pressing challenges to global health, undermining decades of medical progress and jeopardizing the efficacy of life-saving therapies. In 20...